Y-L. Choi

Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial

Yeon Hee Park, Tae‐Yong Kim, Gun Min Kim et al. · The Lancet Oncology · 2019 · 130 citations

Medicine, Oncology, Pharmacology +16

Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients

Y-L. Choi, Ja Kim, K-T. Jang et al. · British Journal of Dermatology · 2006 · 98 citations

Medicine, Infectious Diseases, Pathology +17

Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables

JH Park, Y-L. Choi, J-H. Namkung et al. · British Journal of Dermatology · 2006 · 92 citations

Life Sciences, Dermatology, Immunology +17

Clinical significance of CD151 overexpression in subtypes of invasive breast cancer

Mi Kwon, S Park, Jung Yun Choi et al. · British Journal of Cancer · 2012 · 88 citations · Full text

Medicine, Oncology, Pathology +13

Extranodal NK / T-cell lymphoma with cutaneous involvement: ‘nasal’ vs. ‘nasal-type’ subgroups- a retrospective study of 18 patients

Y-L. Choi, JH Park, J-H. Namkung et al. · British Journal of Dermatology · 2008 · 88 citations

Medicine, Dermatology, Oncology +13